# Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia

> **NCT00276601** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins**

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** arsenic trioxide
- **DRUG:** cytarabine
- **DRUG:** daunorubicin hydrochloride
- **DRUG:** mercaptopurine
- **DRUG:** methotrexate
- **DRUG:** tretinoin

## Key facts

- **NCT ID:** NCT00276601
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-12
- **Final completion:** 2013-06
- **Target enrollment:** — (—)
- **Last updated:** 2014-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00276601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00276601, "Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00276601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*